Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-22-000329
Date:2022-01-04
Issuer: HEALTH CATALYST, INC. (HCAT)
Original Submission Date:

Reporting Person:

LLEWELYN LINDA
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN, UT 84095

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-01-04 M 2,050 a $10.80 33,016 direct
COMMON STOCK 2022-01-04 M 1,100 a $11.78 34,116 direct
COMMON STOCK 2022-01-04 S 3,234 d $40.23 30,882 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 11.78 2022-01-04 deemed execution date M 1,100 (d) 2028-01-24 common stock 1,100 $11.78 4,754 direct
STOCK OPTION (RIGHT TO BUY) 10.8 2022-01-04 deemed execution date M 2,050 (d) 2028-09-27 common stock 950 $10.80 6,920 direct
Footnotes
IDfootnote
f1 the sale reported on this form 4 was made pursuant to a written trading plan adopted by the reporting person on december 9, 2020, in accordance with rule 10b5-1.
f2 25% of the 17,954 shares underlying the options vested in an annual installment on january 24, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on january 24, 2022.
f3 25% of the 59,351 shares underlying the options vested in an annual installment on september 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on september 25, 2022.

Elevate your investments